SpaceX IPO Draws $150 Billion in Orders, Twice Oversubscribed

Cover image from westernjournal.com, which was analyzed for this article
SpaceX's planned IPO drew massive institutional interest with orders exceeding $10 billion.
PoliticalOS
Tuesday, June 9, 2026 — Business
Strong institutional demand has already doubled the planned raise, yet retail investors face uncertain access because final allocations occur only after June 11 pricing. The fixed share price and large retail earmark distinguish this offering but do not guarantee participation for every interested buyer.
What outlets missed
Neither outlet examined how the fixed $135 price interacts with the two-times oversubscription to affect aftermarket trading volatility. The Motley Fool piece did not address whether the greenshoe mechanism would be activated or how partial retail allocations might influence secondary-market buying pressure. Western Journal provided no data on actual infrastructure capacity constraints that could limit SpaceX scaling even after the IPO raises capital.
SpaceX Prepares for Landmark IPO With Strong Retail Demand Raising Questions
SpaceX is moving ahead with plans for what could become the largest initial public offering in history, with shares expected to hit the market as soon as June 12 at a fixed price of 135 dollars each. The company, led by Elon Musk, aims for a valuation reaching 1.77 trillion dollars, drawing intense interest from investors across the board. Reports indicate the offering is already oversubscribed, meaning demand far outstrips the available shares.
Unlike most IPOs, where retail investors typically receive only 5 to 10 percent of the allocation, SpaceX has reserved about 30 percent of shares for non-professional buyers. Brokerages such as Robinhood and Charles Schwab have extended invitations to customers, allowing ordinary individuals to place orders ahead of the listing. This approach stands out in an industry where big institutions usually dominate early access, and it comes as Musk's broader portfolio of ventures, including Starlink and xAI, continues to expand rapidly.
Behind the headlines of rockets and record valuations lies a more complex picture of infrastructure demands. Scaling operations of this magnitude requires substantial power generation, specialized equipment, and hardware that cannot be assembled quickly. Analysts note that suppliers in these areas stand to benefit quietly as the company builds out its capabilities, even as public attention focuses on the IPO itself. Promotional materials from investment outlets have highlighted these indirect players, suggesting they could see movement once the roadshow begins and wider awareness grows.
The push to include retail investors more prominently has sparked discussion about fairness in access. While the larger share allocation appears inclusive on the surface, the oversubscription signals that many participants may end up with limited or no shares once allocations are finalized. This dynamic often favors those with established relationships at major firms, leaving smaller investors to navigate crowded platforms where execution can vary.
Musk's companies have long relied on a mix of private funding, government contracts, and public enthusiasm to reach this stage. The IPO timing coincides with heightened scrutiny over how such massive valuations translate into real-world delivery, particularly given the capital-intensive nature of space and satellite infrastructure. Investors positioning themselves now are betting on sustained growth, yet the fixed pricing and event-style marketing add layers of uncertainty typical in high-profile tech listings.
As the process unfolds, attention is turning to the broader ecosystem supporting these ambitions. Companies involved in energy, manufacturing, and related hardware could experience ripple effects, even if they remain outside the direct spotlight of the SpaceX offering. For those following the story, the coming weeks will test whether the enthusiasm translates into stable participation or reveals gaps between expectation and outcome.
You just read Progressive's take. Want to read what actually happened?
More in Business & Economy

GSK Buys Nuvalent for $10.6 Billion to Strengthen Lung Cancer Pipeline
GSK agreed to buy US cancer drugmaker Nuvalent for $10.6 billion in its largest-ever acquisition.

Tech Stocks Tumble as Iran-Israel Strikes Renew Rate Fears
Major indexes tumbled with tech and AI stocks hit hardest as Iran-Israel clashes and economic worries mounted. Nasdaq futures later showed signs of rebound.
US Labor Market Stagnates as AI Slows Entry-Level Hiring
The labor market faces stagnation with low hiring and firing rates, while AI is reshaping entry-level roles and prompting companies like Goldman Sachs to adjust hiring plans.

SpaceX Sets $135 Share Price for Record $74.4 Billion IPO
SpaceX filed for an IPO targeting up to $75 billion valuation, the largest ever, with implications for Musk's wealth and tech listings.